Further gene therapy technology with the ELEVECTA producer cell line

Delivering on the promise of adeno-associated virus (AAV)-based gene therapies beyond rare diseases will require large quantities of high-quality AAV. In this application note, explore how the Cytiva ELEVECTA^® producer cell line is produced in a robust manner, and is a stable cell line for inducible AAV production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome and requires only a single induction step to initiate AAV production.